In this episode, Mike and I discuss his new blog post about the 10 risks life science companies will face in 2021.
Mike Cremeans Bio: He leads the Life Sciences Practice for Hylant, whose mission is to strengthen the businesses, employees and communities of our client family by embracing them as our own. He is a client facing risk strategist and recognized subject matter expert for Life Sciences related products and services and partner with his customers to identify, simplify and translate complicated risks/situations into understandable concepts and practical solutions.
Project Medtech